The first-line treatment of HTN could be chosen from the following classes: angiotensin receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACE inhibitors), calcium channel blockers (CCBs), and thiazide-type diuretics. This evidence concerns the gene ACE and hypertensive disorder.